NxStage Medical, Inc.
Healthcare · Electromedical & Electrotherapeutic Apparatus · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | $301.5M | $263.4M | $242.1M |
| Operating income | −$1.7M | −$975,000 | −$14.6M | −$22.2M | −$17.8M | −$11.2M |
| Net income | −$1.2M | −$1.3M | −$15.3M | −$23.9M | −$18.6M | −$15.2M |
| Total assets | $325.6M | $317.2M | $306.9M | $309.7M | $307.0M | $311.9M |
| Total liabilities | $112.6M | $115.1M | $113.1M | $118.2M | $112.2M | $114.4M |
| Equity | $213.2M | $201.4M | $191.8M | $190.5M | $194.2M | $197.6M |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 65.2M | 64.1M | 62.7M | 61.2M | 59.3M | 55.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2017- Operating margin
- —
- Net margin
- —
- Return on equity
- −0.6%
- Return on assets
- −0.4%
- Return on capital (ROCE)
- −0.6%
- Liabilities / assets
- 34.6%
- Debt / equity
- 0.53×
- Book value / share
- $3.27
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2017- Altman Z″ (distress)
- -0.13distress
- Accruals / assets
- −1.8%clean
- Piotroski F-Score
- 5/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 3 good- Altman Z″ in the distress zone
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsFeb 22, 2019
- Entered a material agreementJan 29, 2019
- Entered a material agreementOct 30, 2018
- Entered a material agreementJul 30, 2018
- Other material eventJul 18, 2018
- Shareholder voteMay 29, 2018
- Shareholder voteOct 27, 2017
- Other material eventOct 19, 2017
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- CT ORDERApr 24, 2020
- CT ORDERDec 31, 2019
- CT ORDERDec 31, 2019
- CT ORDERDec 31, 2019
- CT ORDERDec 31, 2019
- SC 13G/AAQR CAPITAL MANAGEMENT LLCDec 23, 2019
- CT ORDEROct 3, 2019
- CT ORDERJun 5, 2019
- 15-12GMar 5, 2019
- 4PRIMARY DOCUMENTFeb 25, 2019
- 4PRIMARY DOCUMENTFeb 25, 2019
- 4PRIMARY DOCUMENTFeb 25, 2019
- 4PRIMARY DOCUMENTFeb 25, 2019
- 4PRIMARY DOCUMENTFeb 25, 2019
- 4PRIMARY DOCUMENTFeb 25, 2019
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.